相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。EpCAM-based assays for epithelial tumor cell detection in cerebrospinal fluid
Mark T. J. van Bussel et al.
JOURNAL OF NEURO-ONCOLOGY (2018)
Clinical significance of detecting CSF-derived tumor cells in breast cancer patients with leptomeningeal metastasis
Xuelu Li et al.
ONCOTARGET (2018)
Unique genetic profiles from cerebrospinal fluid cell-free DNA in leptomeningeal metastases of EGFR-mutant non-small-cell lung cancer: a new medium of liquid biopsy
Y. S. Li et al.
ANNALS OF ONCOLOGY (2018)
Molecular Profiling of Liquid Biopsy Samples for Precision Medicine
Camila D. M. Campos et al.
CANCER JOURNAL (2018)
Association of Cell-Free DNA Tumor Fraction and Somatic Copy Number Alterations With Survival in Metastatic Triple-Negative Breast Cancer
Daniel G. Stover et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Clinical trial design for local therapies for brain metastases: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group
Brian M. Alexander et al.
LANCET ONCOLOGY (2018)
Clinical trial design for systemic agents in patients with brain metastases from solid tumours: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group
D. Ross Camidge et al.
LANCET ONCOLOGY (2018)
Cell-Cycle and DNA-Damage Response Pathway Is Involved in Leptomeningeal Metastasis of Non-Small Cell Lung Cancer
Yun Fan et al.
CLINICAL CANCER RESEARCH (2018)
Liquid biopsy for brain tumors
Ganesh M. Shankar et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2017)
Applications of DNA-Based Liquid Biopsy for Central Nervous System Neoplasms
Joanna Wang et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2017)
Integrating liquid biopsies into the management of cancer
Giulia Siravegna et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Cerebrospinal fluid circulating tumor cells: a novel tool to diagnose leptomeningeal metastases from epithelial tumors
Xuling Lin et al.
NEURO-ONCOLOGY (2017)
Detection of Driver and Resistance Mutations in Leptomeningeal Metastases of NSCLC by Next-Generation Sequencing of Cerebrospinal Fluid Circulating Tumor Cells
Ben-Yuan Jiang et al.
CLINICAL CANCER RESEARCH (2017)
Clinical Implications of Monitoring Circulating Tumor DNA in Patients with Colorectal Cancer
Lone V. Scholer et al.
CLINICAL CANCER RESEARCH (2017)
The APPLE Trial: Feasibility and Activity of AZD9291 (Osimertinib) Treatment on Positive PLasma T790M in EGFR-mutant NSCLC Patients. EORTC 1613
Jordi Remon et al.
CLINICAL LUNG CANCER (2017)
EANO-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with leptomeningeal metastasis from solid tumours
E. Le Rhun et al.
ANNALS OF ONCOLOGY (2017)
Overexpression of syndecan-1, MUC-1, and putative stem cell markers in breast cancer leptomeningeal metastasis: a cerebrospinal fluid flow cytometry study
Iole Cordone et al.
BREAST CANCER RESEARCH (2017)
Screening of Carcinoma Metastasis by Flow Cytometry: A Study of 238 Cases
Maria Acosta et al.
CYTOMETRY PART B-CLINICAL CYTOMETRY (2016)
EpCAM-based flow cytometry in cerebrospinal fluid greatly improves diagnostic accuracy of leptomeningeal metastases from epithelial tumors
Bojana Milojkovic Kerklaan et al.
NEURO-ONCOLOGY (2016)
Pooled Analysis of the Prognostic Relevance of Circulating Tumor Cells in Primary Breast Cancer
Wolfgang J. Janni et al.
CLINICAL CANCER RESEARCH (2016)
The Liquid Biopsy: the Role of Circulating DNA and RNA in Central Nervous System Tumors
Ian D. Connolly et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2016)
Evaluating Cancer of the Central Nervous System Through Next-Generation Sequencing of Cerebrospinal Fluid
Elena I. Pentsova et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
SHP-1 promoter 2 methylation in cerebrospinal fluid for diagnosis of leptomeningeal epithelial-derived malignancy (carcinomatous meningitis)
Chanida Vinayanuwattikun et al.
JOURNAL OF NEURO-ONCOLOGY (2016)
Tumor DNA in cerebral spinal fluid reflects clinical course in a patient with melanoma leptomeningeal brain metastases
Yingmei Li et al.
JOURNAL OF NEURO-ONCOLOGY (2016)
Quantification of tumor-derived cell free DNA(cfDNA) by digital PCR (DigPCR) in cerebrospinal fluid of patients with BRAFV600 mutated malignancies
Parisa Momtaz et al.
ONCOTARGET (2016)
Epithelial-to-mesenchymal transition leads to loss of EpCAM and different physical properties in circulating tumor cells from metastatic breast cancer
Kyung-A Hyun et al.
ONCOTARGET (2016)
Diagnostic significance of cerebrospinal fluid EGFR mutation analysis for leptomeningeal metastasis in non-small-cell lung cancer patients harboring an active EGFR mutation following gefitinib therapy failure
Shinichi Sasaki et al.
RESPIRATORY INVESTIGATION (2016)
Digital PCR quantification of MGMT methylation refines prediction of clinical benefit from alkylating agents in glioblastoma and metastatic colorectal cancer
L. Barault et al.
ANNALS OF ONCOLOGY (2015)
Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer
J. Tie et al.
ANNALS OF ONCOLOGY (2015)
Detection of cerebrospinal fluid tumor cells and its clinical relevance in leptomeningeal metastasis of breast cancer
Jin Sun Lee et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Diagnostic and prognostic significance of flow cytometry immunophenotyping in patients with leptomeningeal carcinomatosis
D. Subira et al.
CLINICAL & EXPERIMENTAL METASTASIS (2015)
Detection and Dynamic Changes of EGFR Mutations from Circulating Tumor DNA as a Predictor of Survival Outcomes in NSCLC Patients Treated with First-line Intercalated Erlotinib and Chemotherapy
Tony Mok et al.
CLINICAL CANCER RESEARCH (2015)
Brain Tumor Mutations Detected in Cerebral Spinal Fluid
Wenying Pan et al.
CLINICAL CHEMISTRY (2015)
CellSearch® technology applied to the detection and quantification of tumor cells in CSF of patients with lung cancer leptomeningeal metastasis
Qian Tu et al.
LUNG CANCER (2015)
EGFR mutation detection in ctDNA from NSCLC patient plasma: A cross-platform comparison of leading technologies to support the clinical development of AZD9291
Kenneth S. Thress et al.
LUNG CANCER (2015)
Structural and functional features of central nervous system lymphatic vessels
Antoine Louveau et al.
NATURE (2015)
Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer
Isaac Garcia-Murillas et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma
Leticia De Mattos-Arruda et al.
NATURE COMMUNICATIONS (2015)
Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets
Priscilla K. Brastianos et al.
CANCER DISCOVERY (2015)
Association of EGFR L858R Mutation in Circulating Free DNA With Survival in the EURTAC Trial
Niki Karachaliou et al.
JAMA ONCOLOGY (2015)
Detection of Cancer DNA in Plasma of Patients with Early-Stage Breast Cancer
Julia A. Beaver et al.
CLINICAL CANCER RESEARCH (2014)
MGMT promoter methylation in plasma of glioma patients receiving temozolomide
Valentina Fiano et al.
JOURNAL OF NEURO-ONCOLOGY (2014)
Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data
Francois-Clement Bidard et al.
LANCET ONCOLOGY (2014)
An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
Aaron M. Newman et al.
NATURE MEDICINE (2014)
Acquired resistance to TKIs in solid tumours: learning from lung cancer
D. Ross Camidge et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
Leptomeningeal metastasis: a Response Assessment in Neuro-Oncology critical review of endpoints and response criteria of published randomized clinical trials
Marc Chamberlain et al.
NEURO-ONCOLOGY (2014)
Blockade of EGFR and MEK Intercepts Heterogeneous Mechanisms of Acquired Resistance to Anti-EGFR Therapies in Colorectal Cancer
Sandra Misale et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
Chetan Bettegowda et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Acquired Resistance and Clonal Evolution in Melanoma during BRAF Inhibitor Therapy
Hubing Shi et al.
CANCER DISCOVERY (2014)
Relationship among circulating tumor cells, CEA and overall survival in patients with metastatic colorectal cancer
C. Aggarwal et al.
ANNALS OF ONCOLOGY (2013)
Molecular Profiling of Tumor Cells in Cerebrospinal Fluid and Matched Primary Tumors from Metastatic Breast Cancer Patients with Leptomeningeal Carcinomatosis
Mark Jesus M. Magbanua et al.
CANCER RESEARCH (2013)
Detection and quantification of CSF malignant cells by the CellSearch® technology in patients with melanoma leptomeningeal metastasis
Emilie Le Rhun et al.
MEDICAL ONCOLOGY (2013)
Rare cell capture technology for the diagnosis of leptomeningeal metastasis in solid tumors
Lakshmi Nayak et al.
NEUROLOGY (2013)
Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
Sarah-Jane Dawson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Epithelial Cell Adhesion Molecule-positive Circulating Tumor Cells as Predictive Biomarker in Patients With Prostate Cancer
Robert J. Amato et al.
UROLOGY (2013)
Amplification of the MET Receptor Drives Resistance to Anti-EGFR Therapies in Colorectal Cancer
Alberto Bardelli et al.
CANCER DISCOVERY (2013)
Cerebrospinal fluid concentration of gefitinib and erlotinib in patients with non-small cell lung cancer
Yosuke Togashi et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2012)
Meta-Analysis of the Prognostic Value of Circulating Tumor Cells in Breast Cancer
Liling Zhang et al.
CLINICAL CANCER RESEARCH (2012)
Role of flow cytometry immunophenotyping in the diagnosis of leptomeningeal carcinomatosis
Dolores Subira et al.
NEURO-ONCOLOGY (2012)
A Paravascular Pathway Facilitates CSF Flow Through the Brain Parenchyma and the Clearance of Interstitial Solutes, Including Amyloid β
Jeffrey J. Iliff et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
Development of a new method for identification and quantification in cerebrospinal fluid of malignant cells from breast carcinoma leptomeningeal metastasis
Emilie Le Rhun et al.
BMC CLINICAL PATHOLOGY (2012)
External Quality Assurance of Circulating Tumor Cell Enumeration Using the CellSearch® System: A Feasibility Study
Jaco Kraan et al.
CYTOMETRY PART B-CLINICAL CYTOMETRY (2011)
Identification and enumeration of circulating tumor cells in the cerebrospinal fluid of breast cancer patients with central nervous system metastases
Akshal S. Patel et al.
ONCOTARGET (2011)
Circulating Tumor Cells in the Management of Breast Cancer
Govardhanan Nagaiah et al.
CLINICAL BREAST CANCER (2010)
Circulating mutant DNA to assess tumor dynamics
Frank Diehl et al.
NATURE MEDICINE (2008)
Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer:: A validation study of the CellSearch system
Sabine Riethdorf et al.
CLINICAL CANCER RESEARCH (2007)
Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival
Daniel F. Hayes et al.
CLINICAL CANCER RESEARCH (2006)
Circulating tumor cells, disease progression, and survival in metastatic breast cancer
M Cristofanilli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
分享论文
